Avotaciclib
Avotaciclib Uses, Dosage, Side Effects, Food Interaction and all others data.
Avotaciclib is under investigation in clinical trial NCT03579836 (Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient With Pancreatic Cancer).
| Trade Name | Avotaciclib |
| Generic | Avotaciclib |
| Avotaciclib Other Names | 2,6-bis(2-aminopyrimidin-4-yl)pyridin-3-ol, Avotaciclib |
| Type | |
| Formula | C13H11N7O |
| Weight | Average: 281.279 Monoisotopic: 281.102508002 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Avotaciclib
